AFJKUAimei Health Technology Co. Ltd Unit

NAS · US · Financial Services · Shell Companies

11.81USD0.00%Mkt Cap: —P/E: —4d ago

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more bus…

Industry Peers

Shell Companies

Drugs Made In America Acquisition II Corp. Ordinary Shares

$645.92MUSDP/E 35.0

BCSS

Bain Capital GSS Investment Corp. Class A Ordinary Shares

$600.35MUSD

EVAC

EQV Ventures Acquisition Corp. II

$600.26MUSDP/E 14.7

CXII

Churchill Capital Corp XII Class A Ordinary Shares

$595.50MUSD

CEPF

Cantor Equity Partners IV Inc. Class A Ordinary Shares

$590.93MUSDP/E 27.9

AEXA

American Exceptionalism Acquisition Corp. A

$577.70MUSD

DBCA

D. Boral Acquisition I Corp. Class A Ordinary Shares

$555.37MUSD

VACH

Voyager Acquisition Corp Class A Ordinary Shares

$541.25MUSDP/E 81.5

GCGR

General Catalyst Global Resilience Merger Corp. Class A Ordinary Shares

$514.21MUSD

NWAX

New America Acquisition I Corp. Class A Common Stock

$506.96MUSD

MEVO

M Evo Global Acquisition Corp II Class A Ordinary Shares

$499.00MUSD

KRSP

Rice Acquisition Corporation 3

$487.63MUSD

RFAI

RF Acquisition Corp II Ordinary Shares

$483.94MUSDP/E 483.3

GIW

GigCapital8 Corp. Class A Ordinary Shares

$480.90MUSD

GTEN

Gores Holdings X Inc. Class A ordinary shares

$478.70MUSDP/E 6.9

ANSC

Agriculture & Natural Solutions Acquisition Corporation Class A Ordinary Shares

$476.13MUSDP/E 52.1

CRAN

Crane Harbor Acquisition Corp. II Class A Ordinary Shares

$475.57MUSD

APXT

APEX TECHNOLOGY ACQUISITION CORP

$464.43MUSD

IEAG

Infinite Eagle Acquisition Corp. Class A Ordinary Shares

$444.99MUSD

Key Statistics

Company

Market Cap—

Enterprise Value39.59M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)1.06M $

Revenue/Share—

Last Price11.81 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees—

CountryUS

SectorFinancial Services

IndustryShell Companies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B-8.34

EPS (TTM)—

EPS (Forward)—

52W Range

7.6006% of range80.00

52W High80.00 USD

52W Low7.600 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE13.18%

ROA8.76%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-565.10K $

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt2.19M $

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.25

Current Ratio0.01

Quick Ratio0.00

Book Value/Sh-1.4160 USD

Cash/Share0.0000 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float1.44M

Insiders0.00%

Institutions0.07%

Short Interest

Short Ratio0.1d

Shares Short194

Short (prev mo.)2.31K

Technical

SMA 5023.97 (-50.7%)

SMA 20039.56 (-70.2%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)1.42K

Avg Vol (10d)290

Technical Indicators

RSI (14)15.1

MACD-5.6357

MACD Signal-6.5481

MACD Hist.+0.9124

BB Upper26.75 USD

BB Middle15.12 USD

BB Lower3.499 USD

BB Width153.72%

ATR (14)1.234 USD

Vol Ratio (20d)0.00x